Loading…
CIK 0001056807 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("bvf-inc-il","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| 4D MOLECULAR THERAPEUTICS IN | COM | $17.2M | 0.6%Prev: 0.9% | 4,629,289 SH | Decreased+1,750,000 SH |
| AC IMMUNE SA | SHS | $40.2M | 1.4%Prev: 1.7% | 19,822,436 SH | Decreased |
| ANNEXON INC | COM | $16.8M | 0.6%Prev: 1.5% | 7,000,000 SH | Decreased-1,698,173 SH |
| AVALO THERAPEUTICS INC | COM NEW | $5.1M | 0.2%Prev: 0.8% | 1,028,049 SH | Decreased-604,796 SH |
| AXSOME THERAPEUTICS INC | COM | $176.4M | 6.3% | 1,690,221 SH | New |
| CELCUITY INC | COM | $46.3M | 1.7% | 3,466,000 SH | New |
| CIDARA THERAPEUTICS INC | COM NEW | $38.3M | 1.4% | 786,392 SH | New |
| CRESCENT BIOPHARMA INC. | COM | $22.4M | 0.8%Prev: 1.6% | 1,387,863 SH | Decreased-1,360,900 SH |
| CULLINAN THERAPEUTICS INC | COM | $43.3M | 1.5%Prev: 2.6% | 5,750,683 SH | Decreased |
| ELEDON PHARMACEUTICALS INC | COM | $17.1M | 0.6%Prev: 0.6% | 6,293,282 SH | Decreased |
| ENGENE HOLDINGS INC | *W EXP 10/31/202 | $586K | 0.0%Prev: 0.1% | 945,402 SH | Decreased |
| ESSA PHARMA INC | COM NEW | $14.9M | 0.5% | 8,748,629 SH | New |
| FOGHORN THERAPEUTICS INC | COM | $24.9M | 0.9%Prev: 0.9% | 5,302,000 SH | Decreased-540,000 SH |
| FORTE BIOSCIENCES INC | COM NEW | $7.6M | 0.3% | 588,344 SH | New |
| GH RESEARCH PLC | ORDINARY SHARES | $107.6M | 3.8%Prev: 3.9% | 8,827,712 SH | Decreased+177,554 SH |
| IKENA ONCOLOGY INC | COM | $5.4M | 0.2% | 4,006,564 SH | New |
| IMMUNIC INC | COM | $5.3M | 0.2%Prev: 0.3% | 7,652,972 SH | Decreased |
| IMMUNOCORE HLDGS PLC | ADS | $32.1M | 1.1%Prev: 1.2% | 1,024,288 SH | Decreased-270,175 SH |
| INVENTIVA SA | ADS | $2.1M | 0.1%Prev: 0.1% | 686,040 SH | Decreased |
| IONIS PHARMACEUTICALS INC | COM | $75.6M | 2.7% | 1,913,385 SH | New |
| KURA ONCOLOGY INC | COM | $44.7M | 1.6%Prev: 2.2% | 7,754,129 SH | Decreased-691,640 SH |
| KYMERA THERAPEUTICS INC | COM | $240.1M | 8.6%Prev: 14.6% | 5,502,710 SH | Decreased |
| MIRUM PHARMACEUTICALS INC | COM | $140.5M | 5.0%Prev: 4.7% | 2,761,333 SH | Decreased+1,176,606 SH |
| MOLECULAR PARTNERS AG | ADS | $5.2M | 0.2%Prev: 0.2% | 1,353,968 SH | Decreased |
| MONTE ROSA THERAPEUTICS INC | COM | $25.5M | 0.9%Prev: 2.3% | 5,660,132 SH | Decreased+1,199,246 SH |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | $932.3M | 33.3%Prev: 9.5% | 19,751,284 SH | Increased+3,750,000 SH |
| NLS PHARMACEUTICS LTD | COM NEW | $417K | 0.0% | 143,676 SH | New |
| OLEMA PHARMACEUTICALS INC | COM | $22.6M | 0.8%Prev: 2.5% | 5,295,893 SH | Decreased |
| OVID THERAPEUTICS INC | COM | $1.3M | 0.0% | 3,853,818 SH | New |
| PALVELLA THERAPEUTICS INC NE | COM | $15.7M | 0.6%Prev: 3.8% | 696,555 SH | Decreased-264,434 SH |
| PROTAGONIST THERAPEUTICS INC | COM | $177.5M | 6.3% | 3,211,041 SH | New |
| RAPT THERAPEUTICS INC | COM NEW | $9.2M | 0.3% | 1,154,692 SH | New |
| REPARE THERAPEUTICS INC | COM | $14.4M | 0.5% | 10,333,600 SH | New |
| REVOLUTION MEDICINES INC | COM | $183.3M | 6.5%Prev: 8.9% | 4,982,384 SH | Decreased+2,125,602 SH |
| SAB BIOTHERAPEUTICS INC | COM NEW | $1.6M | 0.1% | 917,826 SH | New |
| SEPTERNA INC | COM | $46.5M | 1.7%Prev: 1.0% | 4,396,124 SH | Increased+3,042,875 SH |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | $36.7M | 1.3%Prev: 5.3% | 1,771,417 SH | Decreased-1,687,941 SH |
| TENAX THERAPEUTICS INC | COM NEW | $2.0M | 0.1%Prev: 0.2% | 339,549 SH | Decreased |
| TSCAN THERAPEUTICS INC | COM | $7.6M | 0.3%Prev: 0.2% | 5,226,074 SH | Increased-338,216 SH |
| TYRA BIOSCIENCES INC | COM | $37.7M | 1.3%Prev: 2.4% | 3,944,194 SH | Decreased+1,967,998 SH |
| VERASTEM INC | COM NEW | $14.1M | 0.5% | 3,404,425 SH | New |
| XENCOR INC | COM | $21.5M | 0.8%Prev: 2.7% | 2,740,141 SH | Decreased-4,393,579 SH |
| XOMA ROYALTY CORPORATION | COM NEW | $65.3M | 2.3%Prev: 2.6% | 2,590,303 SH | Decreased |
| ZYMEWORKS INC | COM | $54.1M | 1.9%Prev: 3.0% | 4,308,935 SH | Decreased+574,793 SH |
| 13F-HR |
| 0000921895-26-002163 |
| $3.91B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000921895-25-002281 | $2.80B | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0000921895-26-001382 | $3.14B | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000921895-25-001528 | $2.45B | View |